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Abstract
Background: Chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) frequently coexist,
significantly reducing patients’ quality of life and increasing morbidity and mortality. For either single disease, a
multidisciplinary disease-management approach supported by telecommunication technologies offers the best
outcome in terms of prolonged survival and reduced hospital readmissions. However, no data exist in patients with
combined COPD/CHF.
We planned a randomized controlled trial to investigate the feasibility and efficacy of an integrated, home-based,
medical/nursing intervention plus a rehabilitation program versus conventional care in patients with coexisting
COPD/CHF. The purpose of the paper is to describe the rationale and design of the trial.
Methods/designs: Patients, after inpatient rehabilitation, were randomly assigned to the intervention or control
group, followed for 4 months at home, then assessed at 4 and 6 months. The intervention group followed a
telesurveillance (telephone contacts by nurse and remote monitoring of cardiorespiratory parameters) and home-
based rehabilitation program (at least three sessions/week of mini-ergometer exercises, callisthenic exercises and
twice weekly pedometer-driven walking, plus telephone contacts by a physiotherapist). Telephone follow-up served
to verify compliance to therapy, maintain exercise motivation, educate for early recognition of signs/symptoms, and
verify the skills acquired. At baseline and 4 and 6 months, the 6-min Walk Test, dyspnea and fatigue at rest,
oxygenation (PaO2/FiO2), physical activity profile (PASE questionnaire), and QoL (Minnesota and CAT questionnaires)
were assessed. During the study, serious clinical events (hospitalizations or deaths) were recorded.
Discussion: Currently, no studies have assessed the impact of a telehealth program in patients with combined
COPD and CHF. Our study will show whether this approach is effective in the management of such complex, frail
patients who are at very high risk of exacerbations.
Trial registration: Network per la prevenzione e la sanità pubblica, CCM, Ministero della Salute “Modelli innovativi
di gestione integrata telegestita ospedale-territorio del malato cronico a fenotipo complesso: studio di
implementazione, validazione e impatto,” registered on 14 January 2014.
ClinicalTrials.gov Identifier: NCT02269618, registered on 17 October 2014.
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Background
The incidence and the prevalence of chronic diseases
have increased steadily in recent decades and are
continuously rising. Ageing is an important current issue
– patients with chronic diseases, such as chronic heart
failure (CHF), chronic obstructive pulmonary disease
(COPD), hypertension, and diabetes, are increasing in
number and living longer [1, 2]. Till now, health care
has been dominated by single-disease approaches lacking
coordination and integration [3]. Although, in real life,
diseases often coexist in the same patient, the approach
to coexistent diseases has been largely neglected. In
particular, COPD and CHF frequently coexist due to
common risk factors, causing a significant deterioration
in these patients’ quality of life (QoL) and increasing
morbidity and mortality [2, 4]. The prevalence of COPD
in CHF patients ranges from 20 to 32 %, while CHF is
prevalent in more than 20 % of patients with COPD
[2, 4, 5]. Patients with combined COPD and CHF are
often frail and are characterized by a high risk of frequent
exacerbations and often the need for rehospitalization,
with the related burden of cost [2]. Each disease is an in-
dependent predictor of morbidity, mortality, impaired
functional status, and health service use [6, 7]. The com-
bination of these two diseases presents many diagnostic
challenges [5]. Clinical symptoms and signs require careful
interpretation, in conjunction with objective evidence for
each condition. Both are chronic progressive diseases with
a course that fluctuates, burdened by frequent exacerba-
tions, through a vicious circle of dyspnea, decreased activ-
ity, new exacerbations [8, 9], depression, and social
isolation, ultimately leading to death [10, 11]. Muscle mass
loss and skeletal muscle wasting in these patients have ser-
ious therapeutic and clinical implications [12]. Muscle at-
rophy contributes to muscle fatigue during exercise,
obliging patients to stop exercising even if they have not
yet exhausted their heart and lung capacity [12, 13].
The weight of evidence from randomized trials in
these single specific diseases indicates that a multidiscip-
linary disease-management approach, supported by tele-
communication technologies, has the best outcome in
terms of prolonged survival and reduced hospital re-
admission rates [14, 15]. However, in patients where
these two chronic diseases coexist there is no similar
evidence to date.
We previously presented, in CHF [16] and COPD pa-
tients [17], a model for a multidisciplinary care approach
using structured telephone support providing medical/
nursing interventions coupled with biosignal telemoni-
toring. This model demonstrated a possible approach for
chronic single-disease treatment after hospitalization,
providing a way to prevent clinical deterioration and
rehospitalizations through a comprehensive, long-term
intervention with regular reinforcement of patient
adherence, knowledge, and skills [18]. No physical re-
habilitation program was included in this model.
Methods/design
Aims
A personalized hospital discharge program appears to be
the best approach for the follow-up care of patients with
combined COPD/CHF. Particularly important for pa-
tients with multiple comorbidities is routine self-
management support, consisting of education to help
patients to recognize symptoms early, manage their
medical devices, identify barriers to adherence to ther-
apy such as adverse effects of drugs, and check that the
intensity of physical therapy is appropriate. Our study
aims to compare the feasibility and efficacy of an inte-
grated, home-based, medical/nursing intervention plus a
physical rehabilitation program versus conventional care
in patients with combined COPD/CHF. The purpose of
this paper is to describe the rationale and design of the
trial.
Design
This is a consecutive, multicenter, open, randomized
controlled trial. All enrolled patients have been followed
for 4 months at home and visited at hospital discharge
(T0), after 4 months (T1) and again after another
2 months (T2), on which occasion the same tests per-
formed at the two previous visits were repeated. A flow
chart of the study design. is shown in Fig. 1.
The study strategy is registered, constructed and pre-
sented according to the recommendations for Interven-
tional Trials (SPIRIT) [19] (SPIRIT checklist, Additional
file 1) and Consolidated Standards of Reporting Trials
(CONSORT) guidelines [20].
Study sites and patient population
Patients were recruited consecutively from the Cardiology
and Pulmonary Departments of three rehabilitation
hospitals in Italy (Salvatore Maugeri Foundation
IRCCS Institutes of Lumezzane and Montescano; and
San Raffaele Pisana IRCCS, Rome). Patient selection
criteria are listed in Table 1. CHF and COPD diag-
noses had to be documented from at least one echo-
cardiogram (CHF) performed within the previous
12 months under clinically stable conditions [21] and
by a spirometry examination (COPD) [6] performed
within the previous 12 months.
Randomization
Consenting eligible patients were randomized to either
an intervention or a control group (1:1). A computer
generated tables to allocate patients in fixed blocks of 4.
In order to prevent selection bias, the allocation se-
quence was concealed from the investigators enrolling
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and assessing patients, in sequentially numbered,
opaque, sealed envelopes.
Due to the nature of the intervention, neither the pa-
tients nor the physicians were blinded to patients’ group
allocation; however, outcome assessors and data analysts
will be blinded.
Trial structure
The trial structure of the study is described in the Table 2.
A specially trained nurse-tutor (NT) and physiotherapist
(PT) screened the electronic patient boards every week
at each rehabilitation hospital for eligible candidates
for the study and checked their eligibility in terms of
the inclusion and exclusion criteria with the study doc-
tor. If any possible candidates had been admitted in
the previous week the patients were informed verbally
and in writing about the study by the study team.
Before discharge from hospital to home (T0), all candi-
dates underwent assessment of arterial blood gases and
nutritional status by Body Mass Index (BMI). Then pa-
tients were also administered the following evaluations
or scales:
1. Evaluation of exercise capacity by the 6-min Walk
Test (6MWT) [22]
2. Assessment of dyspnea in activities of daily living
(ADL) by the Medical Research Council (MRC)
scale [23]
3. Assessment of dyspnea and muscle fatigue in
ADLs by the Borg scale [24] – patients were
asked to report their own sensations referring to
the previous day
Fig. 1 Study flow chart
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4. Evaluation of disability by the Barthel Index [25]
5. Indirect assessment of physical activity by the
Physical Activity Scale for the Elderly (PASE) [26]
6. Assessment of QoL by the Minnesota Living with
Heart Failure Questionnaire (MLHFQ) [27] and by
the COPD Assessment Test (CAT) [28]
Then, patients were randomized into one of the
two groups. The same measurements were repeated
after 4 months (T1) and after a further 2 months of
follow-up (T2).
Only in the patients of the intervention group, we
evaluated:
1. The percentage of the prescribed training sessions
that were actually performed (number of performed
sessions as a percentage of the total scheduled
training sessions); in addition, the PT filled out a
5-point Likert scale (see Table 3) at the T1 visit,
assessing the collaboration and compliance of
patients in the intervention group
2. Satisfaction regarding the assistance was measured
by the patient at T1. The six items, with a score
from 0 (not at all satisfied) to 4 (very satisfied),
enquired about the service as a whole, the use of the
devices, the health care professionals’ willingness to
respond to the patient’s needs, clarity of the
indications and suggestions made by the NT and PT,
the feeling of support, and if the service was felt to
be of real help or not (Table 4)
Interventions
Intervention group
All patients randomized to the intervention group re-
ceived an educational intervention from the NT and PT
and were followed by both during the home program.
Table 1 Eligibility criteria
Inclusion criteria Exclusion criteria
1. Age over 18 years Physical activity limitations due to noncardiac and/or pulmonary conditions
2. Chronic obstructive pulmonary disease (COPD) GOLD classification
(classes B, C, and D) [11]
Limited life expectancy
3. Systolic and/or diastolic heart failure (HF) New York Heart Association
(NYHA) classes II, II, and IV
Severe cognitive impairments
4. At least one hospitalization or visit due to HF or COPD exacerbation
in the previous 12 months
5. Signed informed consent
Table 2 Trial structure of the study
Activity/Assessment Pre visit T0 T1 T2
During
hospitalization
Visit 1 Visit 2 Visit 3





Arterial blood gases X X
Body Mass Index (BMI) X X
6MWT X X X
MRC scale X X X
Borg scale X X X
Barthel Index X X X
PASE X X X
MLHFQ X X X
CAT X X X
Triage to assess the patient’s compliance to the rehabilitation program
(only in the intervention group)
X
Customer satisfaction (only in the intervention group) X
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Nurse program Before discharge from the hospital, all pa-
tients were given instruction about their disease condition.
The home-based telesurveillance program [16, 17] is de-
signed to provide multidisciplinary care through structured
telephone support and telemonitoring. An intensive NT
care management program was created, and a NT followed
the enrolled patients for 4 months. NTs perform a weekly
intervention mainly through structured appointments
(from Monday to Friday from 8:30 a.m. to 4:00 p.m.), col-
lecting information about disease status (blood pressure
and body weight measurements) and symptoms (general
information). Patients were provided with a pulse oximeter
(GIMA, Gessate (MI), Italy), and a portable one-lead elec-
trocardiograph (Card Guard 2206; Card Guard Scientific
Survival Ltd., Rehovot, Israel) and instructed on how to
transmit the electrocardiogram (EKG) trace via a fixed or
mobile telephone line to the NT. Participants in the study
were also informed that additional telesupport from the
NT, aside from the normal weekly NT call, could be
accessed by the patients themselves in the case of urgent
need or emergency. Unscheduled contacts could be made,
24 h/day 365 days/year, to the NT on duty in case of symp-
toms manifesting, signs of possible decompensation, or for
any doubt about therapy. The EKG was transferred during
each call to the telemedicine center, which stored it and
sent it to the hospital unit. At the end of each telephone
call, the NT could provide support to the patient, offering
advice regarding diet, lifestyle, and medications, and sug-
gesting changes in therapy within patient-adapted criteria
previously defined with the cardiologist or pulmonologist
supervising the program, and could fix an appointment for
consultation with the specialist and schedule the next tele-
phone appointment. All conversations were recorded; EKG
tracings, the patient’s clinical data and any suggestions
made were recorded in a personal health electronic record
by the NT. Medical doctors were consulted before referring
any patient to the Emergency Department.
Physiotherapist program Patients were assessed by the
PT who designed a personalized rehabilitation program
to meet each patient’s particular needs. The level and in-
tensity of physical activity were calculated in a rehabilita-
tion triage schedule (Table 5) adding together dyspnea,
meters walked (6MWT), and ADL scores. Based on this
score, patients with a score from 0 to 6 were prescribed
hard training, while patients with a score from 7 to 12
Table 3 Triage to assess a patient’s compliance to the rehabilitation program
0 Nothing: the patient has never followed the changes to the program of retraining provided by the physiotherapist
1 Little: the patient has followed for less than half of the time the information provided by the physiotherapist
2 Medium: the patient has followed for about half of the time the information provided by the physiotherapist
3 Sufficient: the patient has followed for more than half of the time the information provided by the physiotherapist
4 Very much: the patient has always followed the changes to the program of retraining provided by the physiotherapist
Table 4 Customer satisfaction
1. How do you judge the system overall?
a. Not satisfying at all 0
b. Poorly satisfying 1
c. Fairly satisfying 2
d. Quite satisfying 3
e. Very satisfying 4
2. Was it easy to use the devices?
a. Very complicated 0
b. Quite complicated 1
c. Complicated 2
d. Quite easy 3
e. Very easy 4
3. Did you experience difficulties in contacting the service?





4. Were the indications of the health staff clear?
a. Not at all 0
b. Poorly clear 1
c. Fairly clear 2
d. Quite clear 3
e. Very clear 4
5. Do you feel more secure since when you have access to the service?




e. Very much 4
6. Did the access to the service help your family or the people you live with?




e. Very much 4
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were prescribed light training. An educational session
was held where the PT instructed the patients and their
caregivers on how to perform the exercises correctly and
described the rehabilitation goals within the training
period. Patients were provided with the required instru-
ments (weights, mini-ergometer or cycle-ergometer, ped-
ometer, and physical activity diary) and were instructed
in how to utilize them.
In addition, patients were provided with a pamphlet in
which their personalized rehabilitation program was
recorded, and a DVD, recorded at our institute, which
presented a simulation by the PT of all the exercises
prescribed. Recorded on the DVD, each patient could
find the training path that they followed during their
stay in hospital: callisthenic exercises for different body
regions (neck, upper and lower limbs, shoulders, torso),
exercises for strengthening of the limbs, gluteal and
abdominal muscles, stretching and running-on-the-spot
exercises and arm-crank exercises for the upper limbs.
Rehabilitation program The rehabilitation program
started after in-hospital rehabilitation discharge; in gen-
eral, this was 7 days after the patient’s enrollment. The
number and intensity of training sessions were adapted
during the period of the study, or in the case of prob-
lems reported by patients, during telephone contacts.
The “light training” rehabilitation program consisted of:
 15–25 min of exercise with a mini-ergometer
without load three times/week
 30 min of callisthenic exercises three times/week
 Free walking twice a week
The “hard training” rehabilitation program consisted of:
 30–45 min of mini-ergometer with incremental
load (from 0 to 60 watts max), from 3 to 7 days
per week
 30–40 min of muscle reinforcement exercises using
0.5-kg weights, 3 to 7 days per week
 Pedometer-based walking, from 2 to 7 days per
week. The pedometer provided numerical feedback
so that the number of steps could be increased week
by week (increase predicted: 10 % per week)
During the 4 months of training, the program at home
was targeted to reach a moderate or high level of dys-
pnea and/or muscle fatigue according to the Borg scale
at the end of any training session. Based on this assess-
ment, the PT could decide to increase or maintain the
workload. Patients were asked to write down the phys-
ical activity performed daily in a diary and to report it
during the next telephone appointment.
The PT contacted the patient by telephone once a week.
During each scheduled telephone contact, the PT gathered
information about the patient’s general clinical condition
(e.g., asthenia, muscle, and joint pain), physical activity
performed during the week (duration of exercises and
number of steps walked), and clinical parameters before
and after training (blood pressure, heart rate, oxygen sat-
uration, and Borg scale score). The PT verified the training
level of physical activity performed and planned the
rehabilitation targets for the following week (weight use,
increase in number of steps, and duration of exercise).
During the telephone call, the PT also gave extra
reinforcement on the value of lifestyle changes and the
importance of exercise. At the end of each call, the PT en-
tered the data into a personal health electronic record.
Control group
On discharge from in-hospital rehabilitation, patients in
the control group received the standard care program
including medications and oxygen prescription, visits
from the general practitioner, and in-hospital check-ups
on demand. Patients were free to conduct physical activ-
ity without any monitoring or reinforcement provided
by the hospital. At study enrollment, patients were
instructed in an educational session about the desirabil-
ity of maintaining a healthy lifestyle and were invited to
practice daily physical activity as preferred.
Telemedicine Service Center
A Telemedicine Service Center (HTN, Brescia, Italy)
provided technological support, biomedical devices,
Table 5 Rehabilitation triage schedule
Scores Dyspnea 6MWT ADL
0 No dyspnea at usual activity, performed at normal speed, or dyspnea only
at extraordinary activity
1x Dyspnea at harder activity without pauses (climbing > 3 flights of stairs) >350 m Independent
2x Dyspnea at moderate activity with occasional pauses (walking slightly
uphill and climbing <3 flights of stairs
350–300 m Minimal assistance needed
3x Dyspnea at mild activity and light exercise with many pauses (walking,
washing, standing up)
300–250 m Moderate assistance needed
4x Dyspnea at rest, sitting, or lying down <250 m Totally dependent
6MWT 6-min Walk Test, ADL activity of daily living
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and a call center to provide telemonitoring activities, a
database for the data collected (TelMed platform), and
clinical and nursing support during the night and at
weekends through its health personnel, thus guarantee-
ing the 24 h/day service.
Outcome assessments
The primary outcome was exercise tolerance improve-
ment measured by difference in the meters walked in
the 6MWT. The secondary outcomes were: (1) reduc-
tion of hospitalizations for cardiovascular and/or respira-
tory diseases, (2) reduction of hospitalizations for all
causes, (3) improvement of QoL in the MLHFQ and the
CAT, (4) reduction in impairment/disability evaluated by
the Barthel Index, (5) reduction in dyspnea evaluated by
the MRC scale, (6) reduction in dyspnea and fatigue at
rest evaluated by the Borg scale, (7) improvement of
physical activity profile evaluated by the PASE question-
naire and daily steps reported by patients, and (8) im-
provement of oxygenation (PaO2/FiO2).
In the intervention group only, we also evaluated: (1)
adherence to at least 70 % of the prescribed rehabilita-
tion sessions, (2) qualitative evaluation of patients’ com-
pliance to the rehabilitation program, (3) use of health
services, calculated as total and per-person number of
PT and NT scheduled and unscheduled calls, total and
per-person number of PT home visits, total and per-
person number of educational sessions, and total and
per-person time spent by the PT and NT in the study.
Withdrawal
According to Italian research ethics legislation, we in-
formed the patients about their rights as subjects in a
scientific trial and about their discontinuation rights. We
do this to make patients consider participation thor-
oughly to diminish the likelihood of their dropping out.
Patients can withdraw from the trial at their own request
or at the request of their legal representative at any time.
Every withdrawal was recorded in the patient’s “personal
health record” (TelMed).
Data collection, management, and analysis
We collected and managed study data using a shared
web platform (TelMed) made available by the Telemedicine
Service Center. Only relevant staff have logged access to
the key file.
The principal investigators from each scientific discip-
line have a shared responsibility to secure and monitor
data collection and interpretation, and thus they are all
involved in project management, analysis of samples,
data collection, and observations and will all have access
to the final dataset and be jointly involved in the inter-
pretation of results.
Adverse events monitoring
All adverse events that occurred during the 6-month
study observation period will be reported in the final
paper. A serious adverse event is defined as any untoward
medical occurrence resulting in hospitalization or pro-
longation of hospitalization, or which results in a life-
threatening problem, death, or disability. Adverse events
will be defined as any untoward occurrences in study par-
ticipants, potentially related to implementation of the
study protocol. All serious and unexpected adverse events
will be reported to the Ethics Committee as required.
Sample size
A priori sample size was calculated based on previously
published randomized controlled trial (RCT) data on
COPD and CHF rehabilitation [29, 30] using primary
outcome. With an estimated improvement at T1 with
respect to T0 in the treatment group of 30 ± 50 m
(mean ± standard deviation (SD)) on the 6MWT and no
change expected in the control group (0 ± 50 m), at 80 %
of power and a significance level of p < 0.05, our RCT
would need a sample size consisting of at least 44 partic-
ipants in each group. By taking the probability of drop-
outs into account (20–25 % of enrolled patients), we
decided to include at least 55–60 patients in each group.
Statistical analysis
Statistical analysis will be carried out by a certified
health professional using STATA 13.0 software (College
Station, TX, USA). Data will be descriptively analyzed
and presented as percentage or mean ± standard devi-
ation for all clinical variables, median ± interquartile (IQ)
range for variables without a normal distribution, and
percentage for categorical and binary variables. Distribu-
tion and normality of variables will be tested by the
Kolmogorov-Smirnov test. To compare groups at T0,
Student’s t test or the Mann-Whitney-Wilcoxon test for
continuous variables, and the chi-squared test for cat-
egorical variables, will be used.
The effects of training will be analyzed by two-way
analysis of variance (ANOVA) for repeated measures
(time and group). A post hoc analysis will be conducted
when the ANOVA F ratio is significant for Student’s
t test among times and groups, and Bonferroni’s cor-
rection will be applied.
Also, predictive analysis will be performed to detect
the characteristics of improvers and nonimprovers using
multivariate logistic regression.
The level of significance will be set at p < 0.05.
Discussion
With the progressive ageing of the general population,
there is a need to develop more intensive and integrated
rehabilitation interventions for the growing number of
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more complicated, disabled, high-risk patients. The aim
of our study was to provide patients with combined
COPD/CHF (complex and frequently frail patients with
a very high risk of rehospitalization) with an integrated,
multidisciplinary NT- and PT-oriented program at the
time of in-hospital rehabilitation discharge. This would
be characterized by improved knowledge of the signs
and symptoms of their disease, with interventions on
self-management in the use of medications, evaluation
and solution of problems related to exacerbations ac-
cording to a personalized action plan (self-management),
continuous education at a distance with the possible use
of a specialist network for a second opinion via remote
surveillance (self-guided), home visits as needed, and a
guided rehabilitation maintenance program (home care).
Despite the increasing incidence of chronic diseases
and, among them, the high prevalence of CHF and
COPD, there are no studies in the literature dealing with
a similar home-care approach supported by telemedicine
in this patient population, where the coexistence of both
diseases implies a far greater functional deficit and im-
pact on QoL than in other chronic conditions. Through
this program, the NT and PT, with the support of the
physician, actively monitored the clinical situation and
the patient’s physical status, modifying the therapeutic
approach and the workload weekly.
To minimize bias we used consecutive enrollment
and central randomization. Due to the nature of the
trial it was not possible to blind patients and health
care personnel. We tried to standardize as much as
possible the nursing and physiotherapy approach in the
three hospitals involved in patient enrollment, conduct-
ing joint training of staff, organizational meetings and
planning before commencing patient enrollment. The
rehabilitation program adopted at home tried to repro-
duce as much as possible the rehabilitation carried out
in the hospital, at the same time personalizing the pro-
gram to the needs of patients.
The choice of the 6MWT as a primary outcome meas-
ure was motivated by the fact that this is a very sensitive
test to treatments offered in both these diseases and is
among the most frequently used in the literature. The
test measures the distance covered when subjects are
instructed to walk as quickly as they can for 6 min, and
performance on this test has been used as a measure of
cardiovascular exercise capacity, particularly in patients
with congestive heart failure, and chronic lung disease.
The distance covered during the 6MWT has been shown
to be a sensitive measure of heart disease severity and is
a useful predictor of mortality [31].
We also considered it important to monitor dyspnea
and muscle fatigue [23, 32] using the Borg scale; even if
this is a subjective index, it gives important information
on the health status of the patient at any time of the study.
We chose the PASE [26] as a tool to measure the level of
physical activity, as our population is aged 65 years and
older. The PASE consists of self-reported occupational,
household, and leisure items over a 1-week period and
can be administered by telephone, mail, or in person. The
PASE scoring was derived from movement counts from
an electronic physical activity monitor, activity diaries, and
self-assessed activity levels in a general population of non-
institutionalized older persons. The PASE can be used to
measure physical activity in surveys of older people and to
assess the effectiveness of interventions.
The evaluation of QoL is an important indicator of
the effect of the home program and it remains poorly
investigated in telehealth. Most published trials have
been powered to highlight the effectiveness in “hard”
endpoints such as mortality and cardiovascular or re-
spiratory disease-related hospitalizations; consequently,
information on the efficacy of such programs on sur-
rogate outcomes, physical performance, and QoL are
lacking [33, 34]. Other major indexes include patient
satisfaction [35] and adherence to the program car-
ried out [36–38], which we included in our study.
This is a real-life study, in which the complexity, frailty,
age, high risk of exacerbations, and high variability in the
individual response of the patients enrolled in the home
program can have important effects on the expected results.
Trial status
Enrollment of patients started in July 2013 and ended in
October 2014. Follow-up ended in April 2015. The data,
currently being processed, will show whether telehealth
management in combined COPD/CHF – complex, frail
patients at high risk of exacerbations – is effective.
Additional file
Additional file 1: SPIRIT checklist. (DOC 122 kb)
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